Bench-to-Bedside Program

Partner Offices

Funding for Bench-to-Bedside Awards is provided in the following research categories by the entities listed below:

(1) AIDS: Exemplary HIV/AIDS projects aligned with the new overarching HIV/AIDS research priorities will be considered for funding funded.

(2) Behavioral and Social Sciences {Support from Office of Behavioral and Social Sciences Research}: Projects will be considered for funding that facilitate the translation of basic behavioral and social science research findings into effective interventions to prevent disease and to promote and optimize health. Of particular interest are interdisciplinary research and systems thinking and modeling approaches that integrate multiple levels of analysis - from cells to society - of factors that influence health. Key problems in population health where scientists, practitioners, and decision-makers can work together to accelerate the translation, implementation, dissemination, and adoption of behavioral and social sciences research findings are of high priority to OBSSR. The Office has strong interests in the development of behavioral interventions to improve health, studies of gene-environment interactions, adherence (at the patient and provider levels), measurement harmonization, primary care, mobile health, health disparities, shared medical decision-making, the exposome, and other areas.

(3) Dietary Supplements (Support from the Office of Dietary Supplements): Awards in this funding category are designed to promote scientific study of the benefits of dietary supplements in maintaining health and preventing chronic disease and other health-related conditions but not in disease treatment. In the U.S., these ingredients are usually defined as including plant extracts, enzymes, vitamins, minerals amino acids, and hormonal products that are available without prescription and are consumed in addition to the regular diet.

(4) Minority Health and Health Disparities {Support from the National Institute on Minority Health & Health Disparities}: The National Institute on Minority Health and Health Disparities (NIMHD) will fund projects that promote the science of understanding behavioral, biological, environmental, and health system factors that are unique to the minority groups in the US (defined by the US Census as Black/African American, Asian, American Indian/Alaska Native, Pacific Islander, and Latino/Hispanic). NIMHD will also fund projects that advance the science of understanding the factors that lead to adverse outcomes or health disparities in these minority groups, persons of low socioeconomic status, rural residents, and sexual gender minorities. These projects must focus on an area of science/research that supports the overall NIH effort to reduce health disparities.

(5) Rare Diseases {Support from Office of Rare Diseases Research/National Center for Advancing Translational Sciences}: Projects must focus on an area of science/research directly related to a rare disease. An orphan or rare disease is generally considered to have a prevalence of less than 200,000 affected individuals in the United States. Certain diseases with more than 200,000 affected individuals are included but subpopulations of these conditions may be less than the prevalence standard for a rare disease. A comprehensive list of rare diseases, updated regularly, is available at

(6) Women's Health {Office of Research on Women's Health}: Projects will be considered that focus on efforts to improve the health of women through biomedical and behavioral research on the roles of sex and gender in health and disease with particular interest in comparing and contrasting female and male data from cells, animals, tissues in the context of a range of research questions relevant to diseases that affect women. Additional information about ORWH's strategic priorities can be found at: PDF Icon (1.26 MB).

(7) General: Additional meritorious projects that don't fall within the scope of the categories listed above will be considered for funding in the 'general' category.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 06/12/2017

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at